{"disease":{"id":"chikungunya","name":"chikungunya"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06268691","title":"Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating","phase":"NA","overall_status":"COMPLETED","enrollment_count":35000,"lead_sponsor_name":"Rocio Cardenas Sanchez","has_results":false},{"nct_id":"NCT06595745","title":"Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale","phase":"NA","overall_status":"TERMINATED","enrollment_count":15243,"lead_sponsor_name":"Michigan State University","has_results":false},{"nct_id":"NCT04672577","title":"Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Patricia Schlagenhauf","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT03055585","title":"Applying Wolbachia to Eliminate Dengue","phase":"NA","overall_status":"TERMINATED","enrollment_count":8173,"lead_sponsor_name":"Gadjah Mada University","has_results":false},{"nct_id":"NCT05218304","title":"Baromètre Santé Adulte 2021-2022","phase":"NA","overall_status":"SUSPENDED","enrollment_count":5471,"lead_sponsor_name":"Agence Sanitaire et Sociale de Nouvelle Calédonie","has_results":false},{"nct_id":"NCT07163845","title":"Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5354,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT07254702","title":"Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT04343521","title":"Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":4461,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT04546724","title":"Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4128,"lead_sponsor_name":"Valneva Austria GmbH","has_results":true},{"nct_id":"NCT05072080","title":"A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3258,"lead_sponsor_name":"Bavarian Nordic","has_results":true},{"nct_id":"NCT04566484","title":"Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":3210,"lead_sponsor_name":"International Vaccine Institute","has_results":false},{"nct_id":"NCT07520279","title":"Xpert® Tropical Fever Test on GeneXpert® Edge X System","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"Cepheid","has_results":false},{"nct_id":"NCT07347002","title":"Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1200,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT05153018","title":"Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu","phase":"NA","overall_status":"COMPLETED","enrollment_count":1122,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT07517731","title":"Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities","phase":"NA","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT03631719","title":"Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":834,"lead_sponsor_name":"Universidad de Antioquia","has_results":false},{"nct_id":"NCT07112846","title":"Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":830,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT06257810","title":"Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa","phase":"NA","overall_status":"COMPLETED","enrollment_count":804,"lead_sponsor_name":"BioMérieux","has_results":false},{"nct_id":"NCT04650399","title":"A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT07120724","title":"Real-World Study on Chinese Medicine for Treating Chikungunya Fever","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04615364","title":"Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT03690648","title":"Genetic Factors and Immunological Determinism of Persistent Consequences of Chikungunya","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT02831699","title":"The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Mexican Emerging Infectious Diseases Clinical Research Network","has_results":false},{"nct_id":"NCT03206541","title":"Neurologic Manifestations of the Arbovirus Infection in Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04235361","title":"Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University of Stirling","has_results":false},{"nct_id":"NCT03483961","title":"Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":445,"lead_sponsor_name":"Bavarian Nordic","has_results":true},{"nct_id":"NCT05349617","title":"Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":413,"lead_sponsor_name":"Bavarian Nordic","has_results":true},{"nct_id":"NCT04786444","title":"Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":409,"lead_sponsor_name":"Valneva Austria GmbH","has_results":true},{"nct_id":"NCT07126171","title":"A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Jiangsu Kanion Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT02562482","title":"Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06106581","title":"A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT04434846","title":"Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02861586","title":"Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":263,"lead_sponsor_name":"Themis Bioscience GmbH","has_results":true},{"nct_id":"NCT04619823","title":"Virological and Immunological Determinants of Arbovirus Infection in New Caledonia","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT07414524","title":"VLA1553-403 Pregnancy Surveillance Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT06859619","title":"Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":183,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03028441","title":"Phase I Trial of Measles Vectored Chikungungya Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04838574","title":"Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years","phase":"","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT03382964","title":"Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Valneva Austria GmbH","has_results":false},{"nct_id":"NCT04440774","title":"Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03641339","title":"Defining Skin Immunity of a Bite of Key Insect Vectors in Humans","phase":"NA","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07190560","title":"Against Chikungunya Virus and Neonatal Infection","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT03992872","title":"Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Bavarian Nordic","has_results":true},{"nct_id":"NCT04603131","title":"Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Bharat Biotech International Limited","has_results":false},{"nct_id":"NCT03635086","title":"Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Themis Bioscience GmbH","has_results":true},{"nct_id":"NCT03325075","title":"Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"ModernaTX, Inc.","has_results":true},{"nct_id":"NCT03090685","title":"Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya Fever","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Universidade Federal do Ceara","has_results":false},{"nct_id":"NCT06669208","title":"Trial of an Inactivated Chikungunya Virus Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Najit Technologies, Inc.","has_results":false},{"nct_id":"NCT04455919","title":"Yoga for Chronic Chikungunya","phase":"NA","overall_status":"TERMINATED","enrollment_count":42,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Guadeloupe","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}